Bala S. Manian's Insider Trades & SAST Disclosures

Bala S. Manian's most recent trade in Equillium Inc was a trade of 20,000 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2025 20,000 20,000 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 24,000 24,000 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Sale or transfer of securities back to the company at price $ 0.00 per share. 14 Feb 2025 24,000 0 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 20,770 20,770 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Sale or transfer of securities back to the company at price $ 0.00 per share. 14 Feb 2025 20,770 0 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Sale or transfer of securities back to the company at price $ 0.00 per share. 14 Feb 2025 20,634 0 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 20,634 20,634 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 20,000 20,000 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Sale or transfer of securities back to the company at price $ 0.00 per share. 14 Feb 2025 20,000 0 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 12,000 12,000 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Sale or transfer of securities back to the company at price $ 0.00 per share. 14 Feb 2025 12,000 0 - - Director Stock Option (right to buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 20,000 20,000 - - Stock Option (right to buy)
Vaccinex Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2024 10,108 10,108 - - Stock Option (Right to Buy)
Vaccinex Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2024 2,685 2,685 - - Stock Option (Right to Buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2023 20,000 20,000 - - Stock Option (right to buy)
Vaccinex Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2023 143,848 143,848 - - Stock Option (Right to Buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 May 2022 20,000 20,000 - - Stock Option (right to buy)
Vaccinex Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2022 53,254 53,254 - - Stock Option (Right to Buy)
Equillium Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 May 2021 20,770 20,770 - - Stock Option (right to buy)
Vaccinex Inc
Bala S. Manian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 28,586 28,586 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades